|
Name |
Enniatin B1
|
Molecular Formula | C34H59N3O9 | |
IUPAC Name* |
(3S,6R,9S,12R,15S,18R)-3-[(2S)-butan-2-yl]-4,10,16-trimethyl-6,9,12,15,18-penta(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
|
|
SMILES |
CC[C@H](C)[C@H]1C(=O)O[C@@H](C(=O)N([C@H](C(=O)O[C@@H](C(=O)N([C@H](C(=O)O[C@@H](C(=O)N1C)C(C)C)C(C)C)C)C(C)C)C(C)C)C)C(C)C
|
|
InChI |
InChI=1S/C34H59N3O9/c1-16-22(12)25-34(43)46-27(20(8)9)30(39)36(14)23(17(2)3)32(41)44-26(19(6)7)29(38)35(13)24(18(4)5)33(42)45-28(21(10)11)31(40)37(25)15/h17-28H,16H2,1-15H3/t22-,23-,24-,25-,26+,27+,28+/m0/s1
|
|
InChIKey |
UQCSETXJXJTMKO-UMURLBKASA-N
|
|
Synonyms |
Enniatin B1; 19914-20-6; I1MZD05X9S; (3S,6R,9S,12R,15S,18R)-3-[(2S)-butan-2-yl]-4,10,16-trimethyl-6,9,12,15,18-penta(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone; Cyclo((2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-isoleucyl-(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-valyl-(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-valyl); Cyclo[(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-isoleucyl-(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-valyl-(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-valyl]; UNII-I1MZD05X9S; CHEMBL446318; DTXSID70891861; HY-N3807; ZINC49823175; BE162723; CS-0024255; J-012868; Q27280257
|
|
CAS | 19914-20-6 | |
PubChem CID | 11262300 | |
ChEMBL ID | CHEMBL446318 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 653.8 | ALogp: | 6.9 |
HBD: | 0 | HBA: | 9 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 140.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 46 | QED Weighted: | 0.291 |
Caco-2 Permeability: | -5.18 | MDCK Permeability: | 0.00003790 |
Pgp-inhibitor: | 1 | Pgp-substrate: | 0.051 |
Human Intestinal Absorption (HIA): | 0.908 | 20% Bioavailability (F20%): | 0.089 |
30% Bioavailability (F30%): | 0.396 |
Blood-Brain-Barrier Penetration (BBB): | 0.038 | Plasma Protein Binding (PPB): | 90.33% |
Volume Distribution (VD): | 1.26 | Fu: | 3.02% |
CYP1A2-inhibitor: | 0.001 | CYP1A2-substrate: | 0.052 |
CYP2C19-inhibitor: | 0.026 | CYP2C19-substrate: | 0.928 |
CYP2C9-inhibitor: | 0.058 | CYP2C9-substrate: | 0.041 |
CYP2D6-inhibitor: | 0.068 | CYP2D6-substrate: | 0.076 |
CYP3A4-inhibitor: | 0.443 | CYP3A4-substrate: | 0.914 |
Clearance (CL): | 5.968 | Half-life (T1/2): | 0.047 |
hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.981 |
Drug-inuced Liver Injury (DILI): | 0.988 | AMES Toxicity: | 0.011 |
Rat Oral Acute Toxicity: | 0.009 | Maximum Recommended Daily Dose: | 0.012 |
Skin Sensitization: | 0.018 | Carcinogencity: | 0.002 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.005 |
Respiratory Toxicity: | 0.012 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002857 | 0.911 | D0O3YF | 0.297 | ||||
ENC000948 | 0.909 | D0L9HX | 0.294 | ||||
ENC003559 | 0.832 | D0P8IV | 0.293 | ||||
ENC002627 | 0.429 | D0L7LC | 0.201 | ||||
ENC005449 | 0.424 | D05AFC | 0.181 | ||||
ENC001481 | 0.383 | D0J7XL | 0.175 | ||||
ENC003706 | 0.355 | D09HNR | 0.170 | ||||
ENC003645 | 0.309 | D0K7NQ | 0.168 | ||||
ENC003271 | 0.298 | D08FJL | 0.165 | ||||
ENC003375 | 0.293 | D02SBQ | 0.164 |